Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

MAST3: a novel IBD risk factor that modulates TLR4 signaling.

Labbé C, Goyette P, Lefebvre C, Stevens C, Green T, Tello-Ruiz MK, Cao Z, Landry AL, Stempak J, Annese V, Latiano A, Brant SR, Duerr RH, Taylor KD, Cho JH, Steinhart AH, Daly MJ, Silverberg MS, Xavier RJ, Rioux JD.

Genes Immun. 2008 Oct;9(7):602-12. doi: 10.1038/gene.2008.57. Epub 2008 Jul 24.

3.

Innate and adaptive immunity in inflammatory bowel disease.

Geremia A, Biancheri P, Allan P, Corazza GR, Di Sabatino A.

Autoimmun Rev. 2014 Jan;13(1):3-10. doi: 10.1016/j.autrev.2013.06.004. Epub 2013 Jun 15. Review.

PMID:
23774107
4.

Interleukin-23/Th17 pathways and inflammatory bowel disease.

Abraham C, Cho J.

Inflamm Bowel Dis. 2009 Jul;15(7):1090-100. doi: 10.1002/ibd.20894. Review.

PMID:
19253307
5.

The innate immune system and inflammatory bowel disease.

Davies JM, Abreu MT.

Scand J Gastroenterol. 2015 Jan;50(1):24-33. doi: 10.3109/00365521.2014.966321. Review.

PMID:
25523553
6.

Inflammatory bowel disease: review from the aspect of genetics.

Ishihara S, Aziz MM, Yuki T, Kazumori H, Kinoshita Y.

J Gastroenterol. 2009;44(11):1097-108. doi: 10.1007/s00535-009-0141-8. Review.

PMID:
19802731
7.

The Promise of Epigenetics. Has It Delivered New Insights?

Cho JH.

Dig Dis. 2016;34(1-2):12-9. doi: 10.1159/000442919. Epub 2016 Mar 16. Review.

PMID:
26982181

Supplemental Content

Support Center